IBDEI0FO ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15684,1,3,0)
 ;;=3^Anogenital Warts,Verereal
 ;;^UTILITY(U,$J,358.3,15684,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,15684,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,15685,0)
 ;;=R63.0^^61^756^17
 ;;^UTILITY(U,$J,358.3,15685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15685,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,15685,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,15685,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,15686,0)
 ;;=R87.611^^61^756^2
 ;;^UTILITY(U,$J,358.3,15686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15686,1,3,0)
 ;;=3^ASC-H
 ;;^UTILITY(U,$J,358.3,15686,1,4,0)
 ;;=4^R87.611
 ;;^UTILITY(U,$J,358.3,15686,2)
 ;;=^5019669
 ;;^UTILITY(U,$J,358.3,15687,0)
 ;;=R87.610^^61^756^3
 ;;^UTILITY(U,$J,358.3,15687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15687,1,3,0)
 ;;=3^ASC-US
 ;;^UTILITY(U,$J,358.3,15687,1,4,0)
 ;;=4^R87.610
 ;;^UTILITY(U,$J,358.3,15687,2)
 ;;=^5019668
 ;;^UTILITY(U,$J,358.3,15688,0)
 ;;=Z98.82^^61^756^18
 ;;^UTILITY(U,$J,358.3,15688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15688,1,3,0)
 ;;=3^Breast Implant Status
 ;;^UTILITY(U,$J,358.3,15688,1,4,0)
 ;;=4^Z98.82
 ;;^UTILITY(U,$J,358.3,15688,2)
 ;;=^5063747
 ;;^UTILITY(U,$J,358.3,15689,0)
 ;;=B37.3^^61^756^19
 ;;^UTILITY(U,$J,358.3,15689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15689,1,3,0)
 ;;=3^Candidiasis of Vulva & Vagina
 ;;^UTILITY(U,$J,358.3,15689,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,15689,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,15690,0)
 ;;=D06.9^^61^756^20
 ;;^UTILITY(U,$J,358.3,15690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15690,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,15690,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,15690,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,15691,0)
 ;;=D06.0^^61^756^21
 ;;^UTILITY(U,$J,358.3,15691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15691,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,15691,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,15691,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,15692,0)
 ;;=D06.1^^61^756^22
 ;;^UTILITY(U,$J,358.3,15692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15692,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,15692,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,15692,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,15693,0)
 ;;=A56.02^^61^756^23
 ;;^UTILITY(U,$J,358.3,15693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15693,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,15693,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,15693,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,15694,0)
 ;;=N81.12^^61^756^26
 ;;^UTILITY(U,$J,358.3,15694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15694,1,3,0)
 ;;=3^Cystocele,Lateral
 ;;^UTILITY(U,$J,358.3,15694,1,4,0)
 ;;=4^N81.12
 ;;^UTILITY(U,$J,358.3,15694,2)
 ;;=^331535
 ;;^UTILITY(U,$J,358.3,15695,0)
 ;;=N81.11^^61^756^27
 ;;^UTILITY(U,$J,358.3,15695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15695,1,3,0)
 ;;=3^Cystocele,Midline
 ;;^UTILITY(U,$J,358.3,15695,1,4,0)
 ;;=4^N81.11
 ;;^UTILITY(U,$J,358.3,15695,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,15696,0)
 ;;=N81.10^^61^756^28
 ;;^UTILITY(U,$J,358.3,15696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15696,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,15696,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,15696,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,15697,0)
 ;;=R87.614^^61^756^29
 ;;^UTILITY(U,$J,358.3,15697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15697,1,3,0)
 ;;=3^Cytologic Evidence of Malig on Smear of Cervix
 ;;^UTILITY(U,$J,358.3,15697,1,4,0)
 ;;=4^R87.614
 ;;^UTILITY(U,$J,358.3,15697,2)
 ;;=^5019672
 ;;^UTILITY(U,$J,358.3,15698,0)
 ;;=N87.9^^61^756^36
 ;;^UTILITY(U,$J,358.3,15698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15698,1,3,0)
 ;;=3^Dysplasia of Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,15698,1,4,0)
 ;;=4^N87.9
 ;;^UTILITY(U,$J,358.3,15698,2)
 ;;=^5015877
 ;;^UTILITY(U,$J,358.3,15699,0)
 ;;=R30.0^^61^756^37
 ;;^UTILITY(U,$J,358.3,15699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15699,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,15699,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,15699,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,15700,0)
 ;;=N92.1^^61^756^40
 ;;^UTILITY(U,$J,358.3,15700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15700,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
 ;;^UTILITY(U,$J,358.3,15700,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,15700,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,15701,0)
 ;;=Z08.^^61^756^42
 ;;^UTILITY(U,$J,358.3,15701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15701,1,3,0)
 ;;=3^F/U Exam After Malig Neop Treatment
 ;;^UTILITY(U,$J,358.3,15701,1,4,0)
 ;;=4^Z08.
 ;;^UTILITY(U,$J,358.3,15701,2)
 ;;=^5062667
 ;;^UTILITY(U,$J,358.3,15702,0)
 ;;=Z80.3^^61^756^43
 ;;^UTILITY(U,$J,358.3,15702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15702,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,15702,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,15702,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,15703,0)
 ;;=Z80.49^^61^756^44
 ;;^UTILITY(U,$J,358.3,15703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15703,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,15703,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,15703,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,15704,0)
 ;;=Z80.41^^61^756^45
 ;;^UTILITY(U,$J,358.3,15704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15704,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,15704,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,15704,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,15705,0)
 ;;=N73.9^^61^756^48
 ;;^UTILITY(U,$J,358.3,15705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15705,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,15705,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,15705,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,15706,0)
 ;;=N60.32^^61^756^49
 ;;^UTILITY(U,$J,358.3,15706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15706,1,3,0)
 ;;=3^Fibrosclerosis,Left Breast
 ;;^UTILITY(U,$J,358.3,15706,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,15706,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,15707,0)
 ;;=N60.31^^61^756^50
 ;;^UTILITY(U,$J,358.3,15707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15707,1,3,0)
 ;;=3^Fibrosclerosis,Right Breast
 ;;^UTILITY(U,$J,358.3,15707,1,4,0)
 ;;=4^N60.31
 ;;^UTILITY(U,$J,358.3,15707,2)
 ;;=^5015779
 ;;^UTILITY(U,$J,358.3,15708,0)
 ;;=Z01.411^^61^756^51
 ;;^UTILITY(U,$J,358.3,15708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15708,1,3,0)
 ;;=3^GYN Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,15708,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,15708,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,15709,0)
 ;;=Z01.419^^61^756^1
 ;;^UTILITY(U,$J,358.3,15709,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15709,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,15709,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,15709,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,15710,0)
 ;;=Z01.419^^61^756^52
 ;;^UTILITY(U,$J,358.3,15710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15710,1,3,0)
 ;;=3^GYN Exam w/ Normal Findings
 ;;^UTILITY(U,$J,358.3,15710,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,15710,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,15711,0)
 ;;=R87.613^^61^756^54
 ;;^UTILITY(U,$J,358.3,15711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15711,1,3,0)
 ;;=3^HGSIL
 ;;^UTILITY(U,$J,358.3,15711,1,4,0)
 ;;=4^R87.613
 ;;^UTILITY(U,$J,358.3,15711,2)
 ;;=^5019671
 ;;^UTILITY(U,$J,358.3,15712,0)
 ;;=R87.612^^61^756^64
 ;;^UTILITY(U,$J,358.3,15712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15712,1,3,0)
 ;;=3^LGSIL
 ;;^UTILITY(U,$J,358.3,15712,1,4,0)
 ;;=4^R87.612
 ;;^UTILITY(U,$J,358.3,15712,2)
 ;;=^5019670
 ;;^UTILITY(U,$J,358.3,15713,0)
 ;;=R92.1^^61^756^68
 ;;^UTILITY(U,$J,358.3,15713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15713,1,3,0)
 ;;=3^Mammographic Calcification on Dx Breast Image
